science
Hosted by Access Infinity · science · EN-US
Brought to you by the team at Access Infinity, this podcast shines a spotlight on the people in market access. In each episode we interview a different industry professional to discover their journey into market access, what inspires them and what they feel is on the horizon for this this ever-changing and exciting industry.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
31%
Guest openness
Selective
Sign up to generate a grounded pitch for Market Access Matters.
Signup to Generate a PitchBrought to you by the team at Access Infinity, this podcast shines a spotlight on the people in market access. In each episode we interview a different industry professional to discover their journey into market access, what inspires them and what they feel is on the horizon for this this ever-changing and exciting industry.
Market Access Matters is hosted by Access Infinity. The show has published 33 episodes to date.
Recent episodes include "Understanding Payer Perceptions with Megan O'Brien" (3 June 2026, 18 minutes), "Pricing Under Pressure: What MFN Really Means for Global Strategy" (3 March 2026, 40 minutes), and "Navigating Global Policy Shifts with Nikhil Taxak" (27 November 2025, 27 minutes).
Market Access Matters publishes roughly every few months, with episodes averaging 24 minutes across 33 episodes.
Booking probability for Market Access Matters is 31%, and the host is rated Selective on guests. Market Access Matters requires a Pod Score of 80 or higher. Market Access Matters's contact route on record: verified email.
The strongest fits for Market Access Matters are Business & Management Consulting. Market Access Matters has a science audience.
Access Infinity hosts Market Access Matters, a science podcast with 33 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #10
<p>In this episode, we hear from Megan O'Brien, Associate Director at Access Infinity, to explore why understanding payer perception is so difficult to capture in a structured way. </p><p>Megan shares how traditional...
Episode #9
<p>Most Favored Nation (MFN) pricing has taken over conversations at conferences, client meetings, and boardrooms alike, but what does it actually mean in practice?</p><p>In this episode, we continue the conversation on...
Episode #8
<p>In this episode we sit down with Nikhil Taxak, Head of Pricing and Market Access Data Analytics at Access Infinity, to explore the rapidly evolving market access landscape.<br/><br/>From the US Most Favored Nation...
Episode #7
<p>In this episode, we're joined by Louisa Oliver Byrne, Senior Consultant at Access Infinity. We learn about the complexities of the Most Favored Nation (MFN) policy and its implications for pharmaceutical market...
Episode #6
<p>In this episode, we invite Access Infinity Partner, Isabel Rubio back to the podcast to explore the unique challenges and innovative solutions reshaping market access and pricing within rare disease. </p><p>Isabel...
Episode #5
<p>In this insightful episode we speak with Lizzie Shanahan, Global Access AI Strategy Lead at Sanofi. With over six years' experience at Sanofi and a rich background in commercial roles, Lizzie shares her unique...
Episode #4
<p>In this episode, we speak with Silvy Mardiguian, Senior Director and Head of HEOR for Europe & New Markets at BeiGene. </p><p>Silvy has been co-leading BeiGene’s preparedness and organisational readiness for the new...
Episode #3
<p>In this episode we chat with Jie Shen, who is Vice President Global Head Market Access at CSL. <br/><br/>Having started her career in pharma before the market access function existed, Jie is an industry veteran. We...
Episode #2
<p>We're kicking off 2025 with a fantastic podcast episode featuring Katrin Jack, Global Access Strategy Head at Galderma and President of the Healthcare Businesswomen's Association Zürich-Zug Chapter. </p><p>This...
Episode #1
<p>In this episode we speak with Ezgi Erdogan who is Oncology Market Access Director for Emerging Markets at GSK. <br/><br/>In this discussion, we cover the unpredictability of emerging markets and the unique challenges...
Episode #8
<p>In this episode, we sit down with Pauline Payen, Director and Global Payer Strategy Lead for UCB’s Early Portfolio. Pauline shares her pragmatic insights into navigating the complexities of global market access...
Episode #7
<p>In this episode we're joined by GSK's Head of Market Access for General Medicines, Rupert Gale. <br/><br/>Rupert has been in pharma for over 27 years and is still going strong! In this discussion, he shares what...
Episode #6
<p>Korinna Karampampa, who is Director Market Access and Pricing at CSL Behring, joins this episode to share her views on sustainable economic development. <br/><br/>Korinna shares what led her into market access and...
Episode #6
<p>In this episode we're joined by our first guest from Biotech - Ning Lu, who is Associate Director, International Pricing & Market Access at Blueprint Medicines.<br/><br/>Ning shares her views on the complexities of...
Episode #5
<p>There’s no doubt that Market Access and Pricing leaders are fast becoming strategic partners in helping their wider organisations to understand the critical role of the function. In this episode, Marco Rauland from...
Episode #4
<p>In this episode we're joined by Yvonne Hilsky who is Director of Market Access at Moderna. Having spent over 30 years in industry, Yvonne shares her views on what it takes to be successful in market access, including...
Episode #3
<p>In this special episode which coincides with Disability Pride Month, we're joined by Senior Analyst Shubham Jadhav. Shubham has Becker Muscular Dystrophy (BMD) which is a form of muscular dystrophy and causes...
Episode #2
<p>Sam is Head of Market Access Canada at Incyte Biosciences Canada and joins the podcast to discuss the evolving market access landscape in Canada. As part of his conversation with Louise, he describes the unique...
Episode #1
<p>In this episode we're joined by Joao Carrasco, Director, Global Market Access Team at Bayer Pharmaceuticals. With a 12+ year career spanning both HEOR and Market Access functions, Joao shares his journey and how his...
Episode #6
<p>In this episode we look at market access through a different lens. We're joined by Becky Germino who has extensive experience in HEOR across a broad range of pharma organisations. <br/>Becky joined Sanofi this year...
Recent guests on Market Access Matters. Study who booked and why before you pitch.
Senior Applications Engineer, Better Business Bureau Cincinnati
Associate Director, International Pricing & Market Access, Colorado School of Mines
Access Infinity
Access Infinity
PitchCentric classifies Market Access Matters under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Pharma Market Access Insights - from Petauri Evidence
The AUScelerate Podcast
pharmaphorum Podcast
Project Medtech
The Pharma Perspective
OnPoint: The Medical Excellence Podcast
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ